Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndrome
Not Applicable
Recruiting
- Conditions
- ambert-Eaton myasthenic syndrome(LEMS)
- Registration Number
- JPRN-UMIN000029085
- Lead Sponsor
- Gunma university graduate school of medicine
- Brief Summary
The study was terminated because the target number of participants was not reached and the study was not evaluable.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
1. serum anti-acetylcholie receptor antibody positive 2. serum anti-MuSK antibody positive 3. pregnancy 4. epilepsy 5. iver dysfunction 6. renal dysfunction 7. abnormal ECG findings 8. the patient who judged inappropriate from the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of Manual Muscle Testing(MMT) and Hand grasping power
- Secondary Outcome Measures
Name Time Method Improvement of repetitive stimulation test findings